Safety and Efficacy of Mix Vaccine in Lung Carcinoma Patient
NCT02333474
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
20
Enrollment
OTHER
Sponsor class
Conditions
Lung Neoplasms
Interventions
BIOLOGICAL:
MV mix vaccine
OTHER:
standard treatment
Sponsor
Fuda Cancer Hospital, Guangzhou